Position in VTRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,628,753
+$22,980,827 QoQ
Shares Held
1,739,846
+405.7% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#65
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TORONTO DOMINION BANK holds $111,614,506 across 11 Drug Manufacturers - Specialty & Generic names. VTRS ranks #3 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
1,813,684 | $44,634,763 | |
| 2 | ZTS |
Zoetis Inc.
|
424,093 | $30,475,322 | |
| 3 | VTRS |
Viatris Inc
This page
|
1,739,846 | $27,628,753 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
5,639 | $3,055,378 | |
| 5 | BHC |
Bausch Health Companies Inc.
|
592,351 | $2,920,290 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
13,405 | $2,259,278 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
66,474 | $298,468 | |
| 8 | TRLV |
Trulieve Cannabis Corp.
|
20,000 | $196,600 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,628,753 | 1,739,846 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,647,926 | 344,036 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,159,434 | 2,824,051 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,329,865 | 235,340 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,313,298 | 259,048 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,655,717 | 419,715 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,053,579 | 646,874 | Shares | Defined | 2025-02-19 | |
| 2024-09-30 | $4,738,202 | 408,114 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $6,348,139 | 597,191 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,185,346 | 685,540 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,270,773 | 671,355 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,119,232 | 620,612 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $6,560,152 | 657,330 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $6,141,801 | 638,441 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,266,775 | 652,900 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,814,667 | 565,102 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $6,952,235 | 664,015 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,306,117 | 763,430 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $10,209,655 | 754,594 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $9,501,516 | 701,219 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $8,014,459 | 560,844 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $11,212,096 | 802,584 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $14,548,086 | 776,312 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||